What is the ticker symbol for OmniAb?

OmniAb trades under the ticker OABI on NASDAQ.

What sector does OmniAb operate in?

OmniAb is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OABI in a portfolio?

PortView shows OABI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

OmniAb (OABI) Stock Analysis

NASDAQHealthcareBiotechnology

$5.23+17.79%

1-year price historyRange $1.36 – $5.10

52-week range$5.23

$1.30$5.23

What OmniAb does

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its industry partners to access a broad spectrum of antibody repertoires and advanced screening techniques, thereby facilitating the development of next-generation treatments. Central to the OmniAb platform is the unique biological capability of proprietary genetically engineered animals, such as OmniRat, OmniChicken, and OmniMouse. These animals are modified to produce human-sequence antibodies, simplifying the creation of human therapeutic candidates. Additionally, OmniAb offers specialized technologies like OmniFlic (a transgenic rat) and OmniClic (a transgenic chicken), which address the requirements for bispecific antibody applications via a common light chain method, as well as OmniTaur, which leverages the distinct structural properties of cow antibodies for challenging targets. The company was founded in 2012 and is based in Emeryville, California.

Key metrics

Market cap

$758.21M

P/E (TTM)

-14.53

EPS (TTM)

$-0.36

Beta

1.22

Dividend yield

0.00%

Revenue / share

$0.30

50-day avg

$2.86

200-day avg

$2.12

52-week high

$5.23

52-week low

$1.30

CEO

Matthew W. Foehr

ETFs linked to OABI

Broad-market and Healthcare sector ETFs an investor holding OmniAb is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how OABI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OABI in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for OmniAb?: OmniAb trades under the ticker OABI on NASDAQ.
Which exchange is OABI listed on?: OABI is listed on NASDAQ.
What sector does OmniAb operate in?: OmniAb is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OABI in a portfolio?: PortView shows OABI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.